- Home
- RVMD vs TOL Comparison
RVMD vs TOL Comparison
Compare RVMD & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | TOL |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 15.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | RVMD | TOL |
|---|---|---|
| Price | $149.27 | $139.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | $135.05 | ★ $164.07 |
| AVG Volume (30 Days) | ★ 2.4M | 1.1M |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $7,143,258,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $411.49 | $5.95 |
| P/E Ratio | ★ N/A | $64.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.00 | $90.78 |
| 52 Week High | $148.00 | $168.36 |
Technical Indicators
Market Signals| Indicator | RVMD | TOL |
|---|---|---|
| Relative Strength Index (RSI) | 86.84 | 49.59 |
| Support Level | $93.39 | $133.98 |
| Resistance Level | N/A | $141.95 |
| Average True Range (ATR) | 4.31 | 3.61 |
| MACD | 6.04 | 1.26 |
| Stochastic Oscillator | 96.35 | 71.45 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About TOL Toll Brothers Inc.
Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.